{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T21:14:41Z","timestamp":1783372481599,"version":"3.54.6"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T00:00:00Z","timestamp":1380499200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1750-9378-8-35","type":"journal-article","created":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:23:26Z","timestamp":1380587006000},"source":"Crossref","is-referenced-by-count":14,"title":["Burkitt Lymphoma: beyond discoveries"],"prefix":"10.1186","volume":"8","author":[{"given":"Sam M","family":"Mbulaiteye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,30]]},"reference":[{"key":"467_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/bjc.1963.7","volume":"17","author":"DH Wright","year":"1963","unstructured":"Wright DH: Cytology and histochemistry of the Burkitt lymphoma. British J Cancer. 1963, 17: 50-55. 10.1038\/bjc.1963.7.","journal-title":"British J Cancer"},{"issue":"197","key":"467_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/bjs.18004619704","volume":"46","author":"D Burkitt","year":"1958","unstructured":"Burkitt D: A sarcoma involving the jaws in African children. Br J Surg. 1958, 46 (197): 218-223. 10.1002\/bjs.18004619704.","journal-title":"Br J Surg"},{"issue":"6","key":"467_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.semcancer.2009.07.001","volume":"19","author":"G Klein","year":"2009","unstructured":"Klein G: Burkitt lymphoma\u2013a stalking horse for cancer research?. Semin Cancer Biol. 2009, 19 (6): 347-350. 10.1016\/j.semcancer.2009.07.001.","journal-title":"Semin Cancer Biol"},{"key":"467_CR4","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S0022-3476(60)80369-1","volume":"56","author":"GT O\u2019Conor","year":"1960","unstructured":"O\u2019Conor GT, Davies JN: Malignant tumors in African children. With special reference to malignant lymphoma. J Pediatr. 1960, 56: 526-535. 10.1016\/S0022-3476(60)80369-1.","journal-title":"J Pediatr"},{"key":"467_CR5","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/1097-0142(196103\/04)14:2<258::AID-CNCR2820140206>3.0.CO;2-7","volume":"14","author":"D Burkitt","year":"1961","unstructured":"Burkitt D, O\u2019Conor GT: Malignant lymphoma in African children I. A clinical syndrome. Cancer. 1961, 14: 258-269. 10.1002\/1097-0142(196103\/04)14:2<258::AID-CNCR2820140206>3.0.CO;2-7.","journal-title":"Cancer"},{"issue":"6","key":"467_CR6","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/ijc.2910020603","volume":"2","author":"D Burkitt","year":"1967","unstructured":"Burkitt D: Burkitt\u2019s lymphoma outside the known endemic areas of Africa and New Guinea. IntJ Cancer J Int du Cancer. 1967, 2 (6): 562-565. 10.1002\/ijc.2910020603.","journal-title":"IntJ Cancer J Int du Cancer"},{"key":"467_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/194232a0","volume":"194","author":"D Burkitt","year":"1962","unstructured":"Burkitt D: A children\u2019s cancer dependent on climatic factors. Nature. 1962, 194: 232-234. 10.1038\/194232a0.","journal-title":"Nature"},{"issue":"7335","key":"467_CR8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein MA, Achong BG, Barr YM: Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma. Lancet. 1964, 1 (7335): 702-703.","journal-title":"Lancet"},{"issue":"3","key":"467_CR9","first-page":"317","volume":"4","author":"JL Ziegler","year":"1977","unstructured":"Ziegler JL, Deisseroth AB, Applebaum FR, Graw RG: Burkitt\u2019s lymphoma\u2013a model for intensive chemotherapy. Seminars Oncol. 1977, 4 (3): 317-323.","journal-title":"Seminars Oncol"},{"issue":"6","key":"467_CR10","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1002\/1097-0142(197612)38:6<2225::AID-CNCR2820380606>3.0.CO;2-F","volume":"38","author":"JL Ziegler","year":"1976","unstructured":"Ziegler JL, DeVita VT, Graw RG, Herzig G, Leventhal BG, Levine AS, Pomeroy TC: Combined modality treatment of American Burkitt\u2019s lymphoma. Cancer. 1976, 38 (6): 2225-2231. 10.1002\/1097-0142(197612)38:6<2225::AID-CNCR2820380606>3.0.CO;2-F.","journal-title":"Cancer"},{"issue":"5349","key":"467_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/237033a0","volume":"237","author":"G Manolov","year":"1972","unstructured":"Manolov G, Manolova Y: Marker band in one chromosome 14 from Burkitt lymphomas. Nature. 1972, 237 (5349): 33-34. 10.1038\/237033a0.","journal-title":"Nature"},{"issue":"24","key":"467_CR12","doi-asserted-by":"publisher","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","volume":"79","author":"R Dalla-Favera","year":"1982","unstructured":"Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM: Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA. 1982, 79 (24): 7824-7827. 10.1073\/pnas.79.24.7824.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"467_CR13","first-page":"1147","volume":"43","author":"G Henle","year":"1969","unstructured":"Henle G, Henle W, Clifford P, Diehl V, Kafuko GW, Kirya BG, Klein G, Morrow RH, Munube GM, Pike P, et al.: Antibodies to Epstein-Barr virus in Burkitt\u2019s lymphoma and control groups. J Nat Cancer Insti. 1969, 43 (5): 1147-1157.","journal-title":"J Nat Cancer Insti"},{"issue":"1","key":"467_CR14","first-page":"19","volume":"42","author":"DP Burkitt","year":"1969","unstructured":"Burkitt DP: Etiology of Burkitt\u2019s lymphoma\u2013an alternative hypothesis to a vectored virus. J Nat Cancer Insti. 1969, 42 (1): 19-28.","journal-title":"J Nat Cancer Insti"},{"issue":"2","key":"467_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nrmicro1089","volume":"3","author":"R Rochford","year":"2005","unstructured":"Rochford R, Cannon MJ, Moormann AM: Endemic Burkitt\u2019s lymphoma: a polymicrobial disease?. Nat Rev Microbiol. 2005, 3 (2): 182-187. 10.1038\/nrmicro1089.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"467_CR16","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V93.2.758","volume":"93","author":"DH Wright","year":"1999","unstructured":"Wright DH: What is Burkitt\u2019s lymphoma and when is it endemic?. Blood. 1999, 93 (2): 758-","journal-title":"Blood"},{"issue":"4","key":"467_CR17","doi-asserted-by":"publisher","first-page":"817","DOI":"10.7326\/0003-4819-70-4-817","volume":"70","author":"PP Carbone","year":"1969","unstructured":"Carbone PP, Berard CW, Bennett JM, Ziegler JL, Cohen MH, Gerber P: NIH clinical staff conference. Burkitt\u2019s tumor. Annals Int Med. 1969, 70 (4): 817-832. 10.7326\/0003-4819-70-4-817.","journal-title":"Annals Int Med"},{"issue":"3","key":"467_CR18","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/1097-0142(197003)25:3<734::AID-CNCR2820250335>3.0.CO;2-1","volume":"25","author":"JL Ziegler","year":"1970","unstructured":"Ziegler JL, Cohen MH, Morrow RH, Kyalwazi SK, Carbone PP: Immunologic studies in Burkitt\u2019s lymphoma. Cancer. 1970, 25 (3): 734-739. 10.1002\/1097-0142(197003)25:3<734::AID-CNCR2820250335>3.0.CO;2-1.","journal-title":"Cancer"},{"issue":"5487","key":"467_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/bmj.1.5487.569","volume":"1","author":"D Burkitt","year":"1966","unstructured":"Burkitt D, Wright D: Geographical and tribal distribution of the African lymphoma in Uganda. British med J. 1966, 1 (5487): 569-573. 10.1136\/bmj.1.5487.569.","journal-title":"British med J"},{"key":"467_CR20","first-page":"217","volume":"60","author":"PH Levine","year":"1985","unstructured":"Levine PH, Connelly RR, McKay FW: Burkitt\u2019s lymphoma in the USA: cases reported to the American Burkitt Lymphoma Registry compared with population-based incidence and mortality data. IARC Sci Publ. 1985, 60: 217-224.","journal-title":"IARC Sci Publ"},{"issue":"3","key":"467_CR21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/pbc.22047","volume":"53","author":"SM Mbulaiteye","year":"2009","unstructured":"Mbulaiteye SM, Biggar RJ, Bhatia K, Linet MS, Devesa SS: Sporadic childhood Burkitt lymphoma incidence in the United States during 1992\u20132005. Pediatric Blood Cancer. 2009, 53 (3): 366-370. 10.1002\/pbc.22047.","journal-title":"Pediatric Blood Cancer"},{"issue":"2","key":"467_CR22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/oxfordjournals.aje.a121444","volume":"96","author":"AL Brodsky","year":"1972","unstructured":"Brodsky AL, Heath CW: Infectious mononucleosis: epidemiologic patterns at United States colleges and universities. Am J Epidemiol. 1972, 96 (2): 87-93.","journal-title":"Am J Epidemiol"},{"issue":"25","key":"467_CR23","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.1182\/blood-2010-03-275917","volume":"116","author":"M Guech-Ongey","year":"2010","unstructured":"Guech-Ongey M, Simard EP, Anderson WF, Engels EA, Bhatia K, Devesa SS, Mbulaiteye SM: AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and\/or biology?. Blood. 2010, 116 (25): 5600-5604. 10.1182\/blood-2010-03-275917.","journal-title":"Blood"},{"issue":"4","key":"467_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ajh.23385","volume":"88","author":"SM Mbulaiteye","year":"2013","unstructured":"Mbulaiteye SM, Clarke CA, Morton LM, Gibson TM, Pawlish K, Weisenburger DD, Lynch CF, Goodman MT, Engels EA: Burkitt lymphoma risk in U.S. solid organ transplant recipients. Am J Hematol. 2013, 88 (4): 245-250. 10.1002\/ajh.23385.","journal-title":"Am J Hematol"},{"issue":"7","key":"467_CR25","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1097\/MPH.0b013e3181e90017","volume":"32","author":"TT Celkan","year":"2010","unstructured":"Celkan TT, Baris S, Ozdemir N, Ozkan A, Apak H, Dogru O, Karaman S, Canbolat A, Ozdil M, Aki H, et al.: Treatment of pediatric Burkitt lymphoma in Turkey. J Pediatric Hematol Oncol. 2010, 32 (7): e279-e284. 10.1097\/MPH.0b013e3181e90017.","journal-title":"J Pediatric Hematol Oncol"},{"issue":"2","key":"467_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1056\/NEJM197707142970202","volume":"297","author":"JL Ziegler","year":"1977","unstructured":"Ziegler JL: Treatment results of 54 American patients with Burkitt\u2019s lymphoma are similar to the African experience. N Engl J Med. 1977, 297 (2): 75-80. 10.1056\/NEJM197707142970202.","journal-title":"N Engl J Med"},{"issue":"11","key":"467_CR27","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","volume":"97","author":"C Patte","year":"2001","unstructured":"Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D, Lutz P, Coze C, Perel Y, Raphael M, et al.: The societe francaise d\u2019Oncologie pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood. 2001, 97 (11): 3370-3379. 10.1182\/blood.V97.11.3370.","journal-title":"Blood"},{"issue":"9726","key":"467_CR28","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/S0140-6736(10)60134-1","volume":"375","author":"SM Mbulaiteye","year":"2010","unstructured":"Mbulaiteye SM, Talisuna AO, Ogwang MD, McKenzie FE, Ziegler JL, Parkin DM: African Burkitt\u2019s lymphoma: could collaboration with HIV-1 and malaria programmes reduce the high mortality rate?. Lancet. 2010, 375 (9726): 1661-1663. 10.1016\/S0140-6736(10)60134-1.","journal-title":"Lancet"},{"issue":"9554","key":"467_CR29","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/S0140-6736(06)69898-X","volume":"368","author":"JA Phillips","year":"2006","unstructured":"Phillips JA: Is Burkitt\u2019s lymphoma sexy enough?. Lancet. 2006, 368 (9554): 2251-2252. 10.1016\/S0140-6736(06)69898-X.","journal-title":"Lancet"},{"issue":"1","key":"467_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1750-9378-7-5","volume":"7","author":"S Baik","year":"2012","unstructured":"Baik S, Mbaziira M, Williams M, Ogwang MD, Kinyera T, Emmanuel B, Ziegler JL, Reynolds SJ, Mbulaiteye SM: A case\u2013control study of Burkitt lymphoma in East Africa: are local health facilities an appropriate source of representative controls?. Infect Agents Cancer. 2012, 7 (1): 5-10.1186\/1750-9378-7-5.","journal-title":"Infect Agents Cancer"},{"issue":"9822","key":"467_CR31","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","volume":"379","author":"EM Molyneux","year":"2012","unstructured":"Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G, Harrison CJ, Israels T, Bailey S: Burkitt\u2019s lymphoma. Lancet. 2012, 379 (9822): 1234-1244. 10.1016\/S0140-6736(11)61177-X.","journal-title":"Lancet"},{"issue":"7418","key":"467_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, et al.: Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012, 490 (7418): 116-120. 10.1038\/nature11378.","journal-title":"Nature"},{"issue":"6","key":"467_CR33","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.semcancer.2009.07.002","volume":"19","author":"GW Bornkamm","year":"2009","unstructured":"Bornkamm GW: Epstein-Barr virus and its role in the pathogenesis of Burkitt\u2019s lymphoma: an unresolved issue. Semin Cancer Biol. 2009, 19 (6): 351-365. 10.1016\/j.semcancer.2009.07.002.","journal-title":"Semin Cancer Biol"},{"key":"467_CR34","volume-title":"APMIS: Acta pathol microbiol et immunol Scand","author":"SM Mbulaiteye","year":"2013","unstructured":"Mbulaiteye SM, Pullarkat ST, Nathwani BN, Weiss LM, Nagesh R, Emmanuel B, Lynch CF, Hernandez B, Neppalli V, Hawes D, et al.: Epstein-Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979\u20132009. APMIS: Acta pathol microbiol et immunol Scand. 2013, doi:10.1111\/apm.12078. Epub ahead of print"},{"issue":"14","key":"467_CR35","doi-asserted-by":"publisher","first-page":"6577","DOI":"10.1073\/pnas.92.14.6577","volume":"92","author":"JR Muller","year":"1995","unstructured":"Muller JR, Janz S, Goedert JJ, Potter M, Rabkin CS: Persistence of immunoglobulin heavy chain\/c-myc recombination-positive lymphocyte clones in the blood of human immunodeficiency virus-infected homosexual men. Proc Natl Acad Sci USA. 1995, 92 (14): 6577-6581. 10.1073\/pnas.92.14.6577.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5673","key":"467_CR36","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/274756a0","volume":"274","author":"G de-The","year":"1978","unstructured":"de-The G, Geser A, Day NE, Tukei PM, Williams EH, Beri DP, Smith PG, Dean AG, Bronkamm GW, Feorino P, et al.: Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt\u2019s lymphoma from Ugandan prospective study. Nature. 1978, 274 (5673): 756-761. 10.1038\/274756a0.","journal-title":"Nature"},{"issue":"5","key":"467_CR37","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nrc2372","volume":"8","author":"RJ Lingwood","year":"2008","unstructured":"Lingwood RJ, Boyle P, Milburn A, Ngoma T, Arbuthnott J, McCaffrey R, Kerr SH, Kerr DJ: The challenge of cancer control in Africa. Nat Rev Cancer. 2008, 8 (5): 398-403. 10.1038\/nrc2372.","journal-title":"Nat Rev Cancer"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-9378-8-35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1750-9378-8-35\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-9378-8-35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T03:00:14Z","timestamp":1596596414000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/1750-9378-8-35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,30]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["467"],"URL":"https:\/\/doi.org\/10.1186\/1750-9378-8-35","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,30]]},"article-number":"35"}}